OMID
Price
$0.02
Change
-$0.00 (-0.00%)
Updated
Jul 2 closing price
Capitalization
N/A
61 days until earnings call
RAFA
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
110.29M
Interact to see
Advertisement

OMID vs RAFA

Header iconOMID vs RAFA Comparison
Open Charts OMID vs RAFABanner chart's image
Omid
Price$0.02
Change-$0.00 (-0.00%)
Volume$900
CapitalizationN/A
Rafarma Pharmaceuticals, Inc. (WY)
Price$0.05
Change-$0.00 (-0.00%)
Volume$10.7K
Capitalization110.29M
OMID vs RAFA Comparison Chart in %
Loading...
OMID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OMID vs. RAFA commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OMID is a Hold and RAFA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (OMID: $0.02 vs. RAFA: $0.05)
Brand notoriety: OMID and RAFA are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: OMID: 2% vs. RAFA: 29%
Market capitalization -- OMID: $0 vs. RAFA: $110.29M
OMID [@Pharmaceuticals: Other] is valued at $0. RAFA’s [@Pharmaceuticals: Other] market capitalization is $110.29M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OMID’s FA Score shows that 1 FA rating(s) are green whileRAFA’s FA Score has 2 green FA rating(s).

  • OMID’s FA Score: 1 green, 4 red.
  • RAFA’s FA Score: 2 green, 3 red.
According to our system of comparison, RAFA is a better buy in the long-term than OMID.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OMID’s TA Score shows that 4 TA indicator(s) are bullish while RAFA’s TA Score has 3 bullish TA indicator(s).

  • OMID’s TA Score: 4 bullish, 3 bearish.
  • RAFA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, OMID is a better buy in the short-term than RAFA.

Price Growth

OMID (@Pharmaceuticals: Other) experienced а +2.86% price change this week, while RAFA (@Pharmaceuticals: Other) price change was -16.07% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.13%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +93.03%.

Reported Earning Dates

OMID is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OMID YTD gains are higher at: -8.861 vs. RAFA (-39.159).
OMIDRAFAOMID / RAFA
CapitalizationN/A110M-
EBITDAN/AN/A-
Gain YTD-8.861-39.15923%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
OMID vs RAFA: Fundamental Ratings
OMID
RAFA
OUTLOOK RATING
1..100
862
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
74
Overvalued
PROFIT vs RISK RATING
1..100
92100
SMR RATING
1..100
13
PRICE GROWTH RATING
1..100
8496
P/E GROWTH RATING
1..100
712
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RAFA's Valuation (74) in the null industry is in the same range as OMID (78). This means that RAFA’s stock grew similarly to OMID’s over the last 12 months.

OMID's Profit vs Risk Rating (92) in the null industry is in the same range as RAFA (100). This means that OMID’s stock grew similarly to RAFA’s over the last 12 months.

OMID's SMR Rating (1) in the null industry is in the same range as RAFA (3). This means that OMID’s stock grew similarly to RAFA’s over the last 12 months.

OMID's Price Growth Rating (84) in the null industry is in the same range as RAFA (96). This means that OMID’s stock grew similarly to RAFA’s over the last 12 months.

RAFA's P/E Growth Rating (2) in the null industry is significantly better than the same rating for OMID (71). This means that RAFA’s stock grew significantly faster than OMID’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OMIDRAFA
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
OMID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TERN4.320.06
+1.41%
Terns Pharmaceuticals
WSBC33.700.42
+1.26%
WesBanco
MBINN19.790.24
+1.23%
Merchants Bancorp
NRT5.100.02
+0.39%
North European Oil Royalty Trust
AA31.15-0.37
-1.17%
Alcoa Corp

OMID and

Correlation & Price change

A.I.dvisor tells us that OMID and OWPC have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OMID and OWPC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OMID
1D Price
Change %
OMID100%
N/A
OWPC - OMID
10%
Poorly correlated
+2.62%
OILFF - OMID
9%
Poorly correlated
+3.58%
RGEDF - OMID
6%
Poorly correlated
N/A
RAFA - OMID
3%
Poorly correlated
N/A
PHCUF - OMID
3%
Poorly correlated
N/A
More

RAFA and

Correlation & Price change

A.I.dvisor tells us that RAFA and SFOSF have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RAFA and SFOSF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAFA
1D Price
Change %
RAFA100%
N/A
SFOSF - RAFA
9%
Poorly correlated
N/A
OWPC - RAFA
7%
Poorly correlated
+2.62%
RSCI - RAFA
7%
Poorly correlated
N/A
SBFM - RAFA
6%
Poorly correlated
-6.06%
PAIOF - RAFA
6%
Poorly correlated
N/A
More